Figure 6From: Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patientsELISPOT linearity of dilution. IFNγ dose response, TIL/PBMC (x-axis) vs. Secreting cells (y-axis) is shown in bar graphs and best-fit linear curve is indicated as solid line. (A) TIL1520 response to gp100209. (B) TIL1235 response to MART-1.Back to article page